- Home
- / US-China Biomedical Technology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
US-China Biomedical Technology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2021-10-06
Market Capitalization
$5.9 K
2021-10-06
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|
| General and administrative expense | 200.2K | 302.3K | 218.9K | 44.0K | 515.5K | 522.1K |
| Operating expense total | 200.2K | 342.3K | 218.9K | 44.0K | 515.5K | 522.1K |
| EBIT | (261.5K) | (844.9K) | (218.9K) | (522.1K) | ||
| Pre tax profit | (262.0K) | (1.0M) | (218.9K) | (44.0K) | (481.3K) | (710.1K) |
| Income tax expense | 800.0 | 818.0 | 1.3K | 800.0 | 906.0 | 800.0 |
| Net Income | (262.8K) | (1.0M) | (220.2K) | (44.8K) | (482.2K) | (710.9K) |